{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:10:45Z","timestamp":1791835845304,"version":"4.3.4"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["P30ES030283"],"award-info":[{"award-number":["P30ES030283"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL125877"],"award-info":[{"award-number":["R01HL125877"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL160927"],"award-info":[{"award-number":["R01HL160927"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Toxicol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12012-024-09836-7","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T20:02:17Z","timestamp":1707249737000},"page":"71-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Diabetic Cardiomyopathy and Cell Death: Focus on Metal-Mediated Cell Death"],"prefix":"10.1007","volume":"24","author":[{"given":"Lu","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kupper","family":"Wintergerst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"issue":"8","key":"9836_CR1","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao, C. W., et al. (2022). Heart disease and stroke statistics-2022 update: A report from the American Heart Association. Circulation, 145(8), e153\u2013e639.","journal-title":"Circulation"},{"issue":"1","key":"9836_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41467-021-27522-y","volume":"13","author":"T Althoff","year":"2022","unstructured":"Althoff, T., et al. (2022). Large-scale diet tracking data reveal disparate associations between food environment and diet. Nature Communications, 13(1), 267.","journal-title":"Nature Communications"},{"issue":"1","key":"9836_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.12202","volume":"13","author":"K El-Kersh","year":"2023","unstructured":"El-Kersh, K., et al. (2023). Metallomics in pulmonary arterial hypertension patients. Pulm Circ, 13(1), e12202.","journal-title":"Pulm Circ"},{"key":"9836_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.116247","volume":"454","author":"J Huang","year":"2022","unstructured":"Huang, J., et al. (2022). Overview of the cardiovascular effects of environmental metals: New preclinical and clinical insights. Toxicology and Applied Pharmacology, 454, 116247.","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"5","key":"9836_CR5","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.3390\/nu15051198","volume":"15","author":"Z Li","year":"2023","unstructured":"Li, Z., et al. (2023). Associations between plasma essential metals levels and the risks of all-cause mortality and cardiovascular disease mortality among individuals with type 2 diabetes. Nutrients, 15(5), 1198.","journal-title":"Nutrients"},{"issue":"6","key":"9836_CR6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","volume":"30","author":"S Rubler","year":"1972","unstructured":"Rubler, S., et al. (1972). New type of cardiomyopathy associated with diabetic glomerulosclerosis. American Journal of Cardiology, 30(6), 595\u2013602.","journal-title":"American Journal of Cardiology"},{"issue":"9","key":"9836_CR7","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan, Y., et al. (2020). Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: Preclinical and clinical evidence. Nature Reviews Cardiology, 17(9), 585\u2013607.","journal-title":"Nature Reviews Cardiology"},{"issue":"6","key":"9836_CR8","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.2337\/diabetes.51.6.1938","volume":"51","author":"L Cai","year":"2002","unstructured":"Cai, L., et al. (2002). Hyperglycemia-induced apoptosis in mouse myocardium: Mitochondrial cytochrome C-mediated caspase-3 activation pathway. Diabetes, 51(6), 1938\u20131948.","journal-title":"Diabetes"},{"issue":"1\u20133","key":"9836_CR9","first-page":"331","volume":"23","author":"H Monkemann","year":"2002","unstructured":"Monkemann, H., et al. (2002). Early molecular events in the development of the diabetic cardiomyopathy. Amino Acids, 23(1\u20133), 331\u2013336.","journal-title":"Amino Acids"},{"issue":"3","key":"9836_CR10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1385\/CT:3:3:219","volume":"3","author":"L Cai","year":"2003","unstructured":"Cai, L., & Kang, Y. J. (2003). Cell death and diabetic cardiomyopathy. Cardiovascular Toxicology, 3(3), 219\u2013228.","journal-title":"Cardiovascular Toxicology"},{"issue":"1","key":"9836_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apsb.2021.08.026","volume":"12","author":"J Wei","year":"2022","unstructured":"Wei, J., et al. (2022). Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy. Acta Pharm Sin B, 12(1), 1\u201317.","journal-title":"Acta Pharm Sin B"},{"key":"9836_CR12","doi-asserted-by":"publisher","first-page":"1135723","DOI":"10.3389\/fcvm.2023.1135723","volume":"10","author":"D Ke","year":"2023","unstructured":"Ke, D., et al. (2023). Ferroptosis, necroptosis and cuproptosis: Novel forms of regulated cell death in diabetic cardiomyopathy. Front Cardiovasc Med, 10, 1135723.","journal-title":"Front Cardiovasc Med"},{"issue":"8","key":"9836_CR13","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/s41401-023-01068-9","volume":"44","author":"SY Sheng","year":"2023","unstructured":"Sheng, S. Y., et al. (2023). Regulated cell death pathways in cardiomyopathy. Acta Pharmacologica Sinica, 44(8), 1521\u20131535.","journal-title":"Acta Pharmacologica Sinica"},{"key":"9836_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108010","volume":"232","author":"S Christgen","year":"2022","unstructured":"Christgen, S., Tweedell, R. E., & Kanneganti, T. D. (2022). Programming inflammatory cell death for therapy. Pharmacology & Therapeutics, 232, 108010.","journal-title":"Pharmacology & Therapeutics"},{"issue":"1","key":"9836_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1152\/physrev.00002.2021","volume":"102","author":"B Tummers","year":"2022","unstructured":"Tummers, B., & Green, D. R. (2022). The evolution of regulated cell death pathways in animals and their evasion by pathogens. Physiological Reviews, 102(1), 411\u2013454.","journal-title":"Physiological Reviews"},{"issue":"8","key":"9836_CR16","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1016\/j.jacc.2006.07.022","volume":"48","author":"L Cai","year":"2006","unstructured":"Cai, L., et al. (2006). Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. Journal of the American College of Cardiology, 48(8), 1688\u20131697.","journal-title":"Journal of the American College of Cardiology"},{"key":"9836_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fphar.2020.00042","volume":"11","author":"Y Chen","year":"2020","unstructured":"Chen, Y., et al. (2020). Distinct types of cell death and the implication in diabetic cardiomyopathy. Frontiers in Pharmacology, 11, 42.","journal-title":"Frontiers in Pharmacology"},{"issue":"2","key":"9836_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41419-023-05639-w","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen, X., et al. (2023). Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. Cell Death & Disease, 14(2), 105.","journal-title":"Cell Death & Disease"},{"issue":"3","key":"9836_CR19","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1385\/CT:1:3:181","volume":"1","author":"L Cai","year":"2001","unstructured":"Cai, L., & Kang, Y. J. (2001). Oxidative stress and diabetic cardiomyopathy: A brief review. Cardiovascular Toxicology, 1(3), 181\u2013193.","journal-title":"Cardiovascular Toxicology"},{"issue":"10","key":"9836_CR20","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.3390\/ijms22105094","volume":"22","author":"FF Jubaidi","year":"2021","unstructured":"Jubaidi, F. F., et al. (2021). The potential role of flavonoids in ameliorating diabetic cardiomyopathy via alleviation of cardiac oxidative stress, inflammation and apoptosis. International Journal of Molecular Sciences, 22(10), 5094.","journal-title":"International Journal of Molecular Sciences"},{"key":"9836_CR21","doi-asserted-by":"crossref","first-page":"6617816","DOI":"10.1155\/2021\/6617816","volume":"2021","author":"Y Chen","year":"2021","unstructured":"Chen, Y., et al. (2021). RIPK3-mediated necroptosis in diabetic cardiomyopathy requires CaMKII activation. Oxidative Medicine and Cellular Longevity, 2021, 6617816.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"key":"9836_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.791848","volume":"12","author":"Y Lu","year":"2021","unstructured":"Lu, Y., et al. (2021). Pyroptosis and its regulation in diabetic cardiomyopathy. Frontiers in Physiology, 12, 791848.","journal-title":"Frontiers in Physiology"},{"key":"9836_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.985020","volume":"9","author":"Y Jia","year":"2022","unstructured":"Jia, Y., et al. (2022). Potential diabetic cardiomyopathy therapies targeting pyroptosis: A mini review. Frontiers in Cardiovascular Medicine, 9, 985020.","journal-title":"Frontiers in Cardiovascular Medicine"},{"issue":"8","key":"9836_CR24","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.tips.2021.05.001","volume":"42","author":"K Roemhild","year":"2021","unstructured":"Roemhild, K., et al. (2021). Iron metabolism: Pathophysiology and pharmacology. Trends in Pharmacological Sciences, 42(8), 640\u2013656.","journal-title":"Trends in Pharmacological Sciences"},{"issue":"9","key":"9836_CR25","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.3390\/ijms22094591","volume":"22","author":"AS Vogt","year":"2021","unstructured":"Vogt, A. S., et al. (2021). On iron metabolism and its regulation. International Journal of Molecular Sciences, 22(9), 4591.","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"9836_CR26","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2174\/092986709787002862","volume":"16","author":"Q Liu","year":"2009","unstructured":"Liu, Q., et al. (2009). Role of iron deficiency and overload in the pathogenesis of diabetes and diabetic complications. Current Medicinal Chemistry, 16(1), 113\u2013129.","journal-title":"Current Medicinal Chemistry"},{"issue":"5","key":"9836_CR27","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J., et al. (2012). Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 149(5), 1060\u20131072.","journal-title":"Cell"},{"issue":"1","key":"9836_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","volume":"20","author":"X Fang","year":"2023","unstructured":"Fang, X., et al. (2023). The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease. Nature Reviews Cardiology, 20(1), 7\u201323.","journal-title":"Nature Reviews Cardiology"},{"key":"9836_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.590226","volume":"8","author":"X Chen","year":"2020","unstructured":"Chen, X., et al. (2020). Iron metabolism in ferroptosis. Front Cell Dev Biol, 8, 590226.","journal-title":"Front Cell Dev Biol"},{"key":"9836_CR30","doi-asserted-by":"publisher","first-page":"1193734","DOI":"10.1155\/2022\/1193734","volume":"2022","author":"W Yao","year":"2022","unstructured":"Yao, W., et al. (2022). Inhibition of the NADPH oxidase pathway reduces ferroptosis during septic renal injury in diabetic mice. Oxidative Medicine and Cellular Longevity, 2022, 1193734.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"2","key":"9836_CR31","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.molcel.2018.10.042","volume":"73","author":"M Gao","year":"2019","unstructured":"Gao, M., et al. (2019). Role of mitochondria in ferroptosis. Molecular Cell, 73(2), 354-363.e3.","journal-title":"Molecular Cell"},{"key":"9836_CR32","doi-asserted-by":"publisher","first-page":"9999612","DOI":"10.1155\/2021\/9999612","volume":"2021","author":"W Sha","year":"2021","unstructured":"Sha, W., et al. (2021). Mechanism of ferroptosis and its role in type 2 diabetes mellitus. Journal of Diabetes Research, 2021, 9999612.","journal-title":"Journal of Diabetes Research"},{"issue":"4","key":"9836_CR33","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.bbrc.2020.01.066","volume":"523","author":"E Dai","year":"2020","unstructured":"Dai, E., et al. (2020). AIFM2 blocks ferroptosis independent of ubiquinol metabolism. Biochemical and Biophysical Research Communications, 523(4), 966\u2013971.","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"14","key":"9836_CR34","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","volume":"185","author":"BR Stockwell","year":"2022","unstructured":"Stockwell, B. R. (2022). Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications. Cell, 185(14), 2401\u20132421.","journal-title":"Cell"},{"issue":"2","key":"9836_CR35","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.apsb.2021.10.005","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang, X., et al. (2022). Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK\/NRF2 pathways. Acta Pharmaceutica Sinica B, 12(2), 708\u2013722.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"9836_CR36","doi-asserted-by":"publisher","first-page":"3159717","DOI":"10.1155\/2022\/3159717","volume":"2022","author":"Z Wei","year":"2022","unstructured":"Wei, Z., et al. (2022). Curcumin attenuates ferroptosis-induced myocardial injury in diabetic cardiomyopathy through the Nrf2 pathway. Cardiovascular Therapeutics, 2022, 3159717.","journal-title":"Cardiovascular Therapeutics"},{"key":"9836_CR37","doi-asserted-by":"publisher","first-page":"3027514","DOI":"10.1155\/2022\/3027514","volume":"2022","author":"S Wu","year":"2022","unstructured":"Wu, S., et al. (2022). 6-Gingerol alleviates ferroptosis and inflammation of diabetic cardiomyopathy via the Nrf2\/HO-1 pathway. Oxidative Medicine and Cellular Longevity, 2022, 3027514.","journal-title":"Oxidative Medicine and Cellular Longevity"},{"issue":"1","key":"9836_CR38","doi-asserted-by":"publisher","first-page":"2180019","DOI":"10.1080\/10641963.2023.2180019","volume":"45","author":"C Liu","year":"2023","unstructured":"Liu, C., et al. (2023). Angiotensin II-induced vascular endothelial cells ferroptosis via P53-ALOX12 signal axis. Clinical and Experimental Hypertension, 45(1), 2180019.","journal-title":"Clinical and Experimental Hypertension"},{"issue":"1\u20132","key":"9836_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/03630260701727077","volume":"32","author":"Y Zheng","year":"2008","unstructured":"Zheng, Y., et al. (2008). The role of zinc, copper and iron in the pathogenesis of diabetes and diabetic complications: Therapeutic effects by chelators. Hemoglobin, 32(1\u20132), 135\u2013145.","journal-title":"Hemoglobin"},{"issue":"2","key":"9836_CR40","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1089\/dna.2019.5097","volume":"39","author":"W Li","year":"2020","unstructured":"Li, W., et al. (2020). Ferroptosis is involved in diabetes myocardial ischemia\/reperfusion injury through endoplasmic reticulum stress. DNA and Cell Biology, 39(2), 210\u2013225.","journal-title":"DNA and Cell Biology"},{"issue":"12","key":"9836_CR41","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.2337\/db19-1176","volume":"69","author":"H Zang","year":"2020","unstructured":"Zang, H., et al. (2020). Autophagy inhibition enables Nrf2 to exaggerate the progression of diabetic cardiomyopathy in mice. Diabetes, 69(12), 2720\u20132734.","journal-title":"Diabetes"},{"issue":"21","key":"9836_CR42","doi-asserted-by":"publisher","first-page":"9995","DOI":"10.1111\/jcmm.16890","volume":"25","author":"T Ni","year":"2021","unstructured":"Ni, T., et al. (2021). Inhibition of the long non-coding RNA ZFAS1 attenuates ferroptosis by sponging miR-150-5p and activates CCND2 against diabetic cardiomyopathy. Journal of Cellular and Molecular Medicine, 25(21), 9995\u201310007.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"9836_CR43","doi-asserted-by":"publisher","first-page":"1011669","DOI":"10.3389\/fendo.2022.1011669","volume":"13","author":"S Du","year":"2022","unstructured":"Du, S., et al. (2022). Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy. Front Endocrinol (Lausanne), 13, 1011669.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9836_CR44","doi-asserted-by":"publisher","DOI":"10.17305\/bb.2022.8846","author":"J Sun","year":"2023","unstructured":"Sun, J., et al. (2023). Exogenous spermidine alleviates diabetic cardiomyopathy via suppressing ROS, ERS and pannexin-1-mediated ferroptosis. Biomolecules and Biomedicine. https:\/\/doi.org\/10.17305\/bb.2022.8846","journal-title":"Biomolecules and Biomedicine"},{"issue":"7","key":"9836_CR45","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1002\/ptr.7798","volume":"37","author":"X Li","year":"2023","unstructured":"Li, X., et al. (2023). Astragaloside IV attenuates myocardial dysfunction in diabetic cardiomyopathy rats through downregulation of CD36-mediated ferroptosis. Phytotherapy Research, 37(7), 3042\u20133056.","journal-title":"Phytotherapy Research"},{"key":"9836_CR46","doi-asserted-by":"publisher","first-page":"1140644","DOI":"10.3389\/fendo.2023.1140644","volume":"14","author":"Y Zhao","year":"2023","unstructured":"Zhao, Y., et al. (2023). Ferroptosis: Roles and molecular mechanisms in diabetic cardiomyopathy. Front Endocrinol (Lausanne), 14, 1140644.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"9836_CR47","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s00424-020-02412-2","volume":"472","author":"J Chen","year":"2020","unstructured":"Chen, J., et al. (2020). The molecular mechanisms of copper metabolism and its roles in human diseases. Pflugers Archiv. European Journal of Physiology, 472(10), 1415\u20131429.","journal-title":"Pflugers Archiv. European Journal of Physiology"},{"issue":"24","key":"9836_CR48","doi-asserted-by":"publisher","first-page":"15304","DOI":"10.1074\/jbc.M115.645069","volume":"290","author":"M Chojnacka","year":"2015","unstructured":"Chojnacka, M., et al. (2015). Cox17 protein is an auxiliary factor involved in the control of the mitochondrial contact site and cristae organizing system. Journal of Biological Chemistry, 290(24), 15304\u201315312.","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"9836_CR49","first-page":"195","volume":"4","author":"G Faa","year":"2000","unstructured":"Faa, G., & Crispino, G. (2000). Molecular interactions in copper metabolism. Advances in clinical pathology, 4(4), 195\u2013201.","journal-title":"Advances in clinical pathology"},{"key":"9836_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114830","volume":"163","author":"D Wang","year":"2023","unstructured":"Wang, D., et al. (2023). The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease. Biomedicine & Pharmacotherapy, 163, 114830.","journal-title":"Biomedicine & Pharmacotherapy"},{"issue":"6586","key":"9836_CR51","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov, P., et al. (2022). Copper induces cell death by targeting lipoylated TCA cycle proteins. Science, 375(6586), 1254\u20131261.","journal-title":"Science"},{"issue":"1","key":"9836_CR52","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen, L., Min, J., & Wang, F. (2022). Copper homeostasis and cuproptosis in health and disease. Signal Transduction and Targeted Therapy, 7(1), 378.","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"2","key":"9836_CR53","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/ijms24021667","volume":"24","author":"S Huo","year":"2023","unstructured":"Huo, S., et al. (2023). ATF3\/SPI1\/SLC31A1 signaling promotes cuproptosis induced by advanced glycosylation end products in diabetic myocardial injury. International Journal of Molecular Sciences, 24(2), 1667.","journal-title":"International Journal of Molecular Sciences"},{"issue":"5","key":"9836_CR54","doi-asserted-by":"publisher","first-page":"681","DOI":"10.21037\/cdt-22-214","volume":"12","author":"HJ Yuan","year":"2022","unstructured":"Yuan, H. J., Xue, Y. T., & Liu, Y. (2022). Cuproptosis, the novel therapeutic mechanism for heart failure: A narrative review. Cardiovascular Diagnosis and Therapy, 12(5), 681\u2013692.","journal-title":"Cardiovascular Diagnosis and Therapy"},{"key":"9836_CR55","doi-asserted-by":"publisher","first-page":"1154920","DOI":"10.3389\/fmolb.2023.1154920","volume":"10","author":"R Bian","year":"2023","unstructured":"Bian, R., et al. (2023). Identification of cuproptosis-related biomarkers in dilated cardiomyopathy and potential therapeutic prediction of herbal medicines. Frontiers in Molecular Biosciences, 10, 1154920.","journal-title":"Frontiers in Molecular Biosciences"},{"issue":"1","key":"9836_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12011-007-8062-y","volume":"122","author":"TG Kazi","year":"2008","unstructured":"Kazi, T. G., et al. (2008). Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biological Trace Element Research, 122(1), 1\u201318.","journal-title":"Biological Trace Element Research"},{"issue":"1","key":"9836_CR57","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s12011-018-1470-3","volume":"189","author":"E Krol","year":"2019","unstructured":"Krol, E., et al. (2019). The relationship between dietary, serum and hair levels of minerals (Fe, Zn, Cu) and glucose metabolism indices in obese type 2 diabetic patients. Biological Trace Element Research, 189(1), 34\u201344.","journal-title":"Biological Trace Element Research"},{"issue":"1","key":"9836_CR58","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1186\/s12889-023-17018-3","volume":"23","author":"X Li","year":"2023","unstructured":"Li, X., et al. (2023). Association of serum copper (Cu) with cardiovascular mortality and all-cause mortality in a general population: A prospective cohort study. BMC Public Health, 23(1), 2138.","journal-title":"BMC Public Health"},{"issue":"9","key":"9836_CR59","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.2337\/diabetes.53.9.2501","volume":"53","author":"GJ Cooper","year":"2004","unstructured":"Cooper, G. J., et al. (2004). Regeneration of the heart in diabetes by selective copper chelation. Diabetes, 53(9), 2501\u20132508.","journal-title":"Diabetes"},{"issue":"6","key":"9836_CR60","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1124\/mol.106.028605","volume":"70","author":"D Gong","year":"2006","unstructured":"Gong, D., et al. (2006). Molecular changes evoked by triethylenetetramine treatment in the extracellular matrix of the heart and aorta in diabetic rats. Molecular Pharmacology, 70(6), 2045\u20132051.","journal-title":"Molecular Pharmacology"},{"key":"9836_CR61","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1475-2840-12-28","volume":"12","author":"J Lu","year":"2013","unstructured":"Lu, J., et al. (2013). Treatment with a copper-selective chelator causes substantive improvement in cardiac function of diabetic rats with left-ventricular impairment. Cardiovascular Diabetology, 12, 28.","journal-title":"Cardiovascular Diabetology"},{"issue":"1","key":"9836_CR62","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bcp.2015.06.027","volume":"97","author":"CC Cheung","year":"2015","unstructured":"Cheung, C. C., et al. (2015). Low-dose copper infusion into the coronary circulation induces acute heart failure in diabetic rats: New mechanism of heart disease. Biochemical Pharmacology, 97(1), 62\u201376.","journal-title":"Biochemical Pharmacology"},{"key":"9836_CR63","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1475-2840-12-123","volume":"12","author":"L Zhang","year":"2013","unstructured":"Zhang, L., et al. (2013). Protection of the heart by treatment with a divalent-copper-selective chelator reveals a novel mechanism underlying cardiomyopathy in diabetic rats. Cardiovascular Diabetology, 12, 123.","journal-title":"Cardiovascular Diabetology"},{"key":"9836_CR64","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/1475-2840-13-100","volume":"13","author":"S Zhang","year":"2014","unstructured":"Zhang, S., et al. (2014). Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation. Cardiovascular Diabetology, 13, 100.","journal-title":"Cardiovascular Diabetology"},{"issue":"2","key":"9836_CR65","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1039\/c9mt00223e","volume":"12","author":"S Zhang","year":"2020","unstructured":"Zhang, S., et al. (2020). Restoration of myocellular copper-trafficking proteins and mitochondrial copper enzymes repairs cardiac function in rats with diabetes-evoked heart failure. Metallomics, 12(2), 259\u2013272.","journal-title":"Metallomics"},{"key":"9836_CR66","doi-asserted-by":"publisher","DOI":"10.1155\/2009\/696378","volume":"2009","author":"JW Baynes","year":"2009","unstructured":"Baynes, J. W., & Murray, D. B. (2009). The metal chelators, trientine and citrate, inhibit the development of cardiac pathology in the Zucker diabetic rat. Experimental Diabetes Research, 2009, 696378.","journal-title":"Experimental Diabetes Research"},{"issue":"4","key":"9836_CR67","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.bbrc.2017.03.127","volume":"486","author":"C Zou","year":"2017","unstructured":"Zou, C., et al. (2017). Deferiprone attenuates inflammation and myocardial fibrosis in diabetic cardiomyopathy rats. Biochemical and Biophysical Research Communications, 486(4), 930\u2013936.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9836_CR68","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12872-016-0288-1","volume":"16","author":"L Brunvand","year":"2016","unstructured":"Brunvand, L., et al. (2016). Early reduced myocardial diastolic function in children and adolescents with type 1 diabetes mellitus a population-based study. BMC Cardiovascular Disorders, 16, 103.","journal-title":"BMC Cardiovascular Disorders"},{"issue":"21","key":"9836_CR69","doi-asserted-by":"publisher","first-page":"12314","DOI":"10.18632\/aging.205181","volume":"15","author":"S Huang","year":"2023","unstructured":"Huang, S., et al. (2023). Cuproptosis-related gene DLAT serves as a prognostic biomarker for immunotherapy in clear cell renal cell carcinoma: Multi-database and experimental verification. Aging (Albany NY), 15(21), 12314\u201312329.","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"9836_CR70","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41589-022-01159-4","volume":"19","author":"V Schulz","year":"2023","unstructured":"Schulz, V., et al. (2023). Functional spectrum and specificity of mitochondrial ferredoxins FDX1 and FDX2. Nature Chemical Biology, 19(2), 206\u2013217.","journal-title":"Nature Chemical Biology"}],"container-title":["Cardiovascular Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-024-09836-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12012-024-09836-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12012-024-09836-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T16:06:16Z","timestamp":1731254776000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12012-024-09836-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["9836"],"URL":"https:\/\/doi.org\/10.1007\/s12012-024-09836-7","relation":{},"ISSN":["1530-7905","1559-0259"],"issn-type":[{"value":"1530-7905","type":"print"},{"value":"1559-0259","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"29 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}